20 May 2022 Actinogen International Clinical Trials Day
04 May 2022 Actinogen Actinogen trial results & strategic update presentation
28 Apr 2022 Eminetra Australia Positive test results for Alzheimer’s drug Xanamem
28 Apr 2022 TechInvest Actinogen announces positive XanaMIA Part A trial
28 Apr 2022 Aged Care News Millions could benefit after breakthrough Alzheimer’s treatment trial by Aussie biotech
28 Apr 2022 Hospital and Healthcare Positive trial results for Alzheimer’s drug Xanamem
27 Apr 2022 Actinogen XanaMIA Part A Trial positive topline results for Xanamem – Webcast 27 April 2022
27 Apr 2022 Biotech Daily Actinogen XanaMIA Phase 1B Part A Trial Meets Endpoints
27 Apr 2022 The Sentiment New trial results from Actinogen hold promise for Alzheimer’s treatment
27 Apr 2022 The Market Herald Actinogen Medical (ASX:ACW) reports positive XanaMIA Part A trial topline results
27 Apr 2022 Kalkine Media Actinogen gets upbeat results from Xanamem trial for Alzheimer’s treatment
27 Apr 2022 Mirage News Millions worldwide could benefit after breakthrough trial in treatment for Alzheimer’s
27 Apr 2022 Actinogen ACW positive XanaMIA results webcast slide presentation
27 Apr 2022 Actinogen Media Release: Millions worldwide could benefit after a breakthrough trial in the treatment for Alzheimer’s by Aussie biotech Actinogen
08 Mar 2022 Actinogen Celebrating International Women’s Day
01 Mar 2022 Actinogen Actinogen CEO presents at Sachs 15th Annual European Life Sciences Conference
28 Feb 2022 Actinogen Raising Awareness on Rare Disease Day
28 February
11 Feb 2022 The Market Herald Actinogen Medical (ASX:ACW) advances Alzheimer’s treatment
09 Feb 2022 The Sentiment Actinogen appoints leading researchers to conduct Phase 2 trials for treatment of Fragile X Syndrome
09 Feb 2022 The Market Herald Actinogen Medical (ASX:ACW) locks in trial manager for FXS phase-two study
09 Feb 2022 Biotech Daily Worldwide To Manage Xanamem Fragile X Trial
26 Jan 2022 Edison Edison Open House Healthcare 2022
10 Jan 2022 Actinogen Actinogen CEO Presents at San Francisco Healthcare Conference
22 Dec 2021 Stockhead Healthcare has been a hot sector. Here are the top ASX biotech stocks in 2021. Best performing ASX biotechs in 2021.
07 Dec 2021 The Market Herald Actinogen Medical (ASX:ACW) partners with Oxford University
07 Dec 2021 Stockhead ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results In other ASX health news this morning: Actinogen Medical (ASX:ACW) has announced strategic collaboration with Oxford University researchers A
29 Nov 2021 The Sentiment Better than a sudoku: could this drug be the key to preventing Alzheimer’s?
25 Nov 2021 Actinogen Actinogen Webcast of Strategic Update and Capital Raising Investor Presentation
25 Nov 2021 Actinogen Actinogen Strategic Update & Capital Raising Investor Presentation
10 Nov 2021 Actinogen Actinogen Annual General Meeting 10 Nov 2021: Webcast presentation
10 Nov 2021 Actinogen Actinogen Annual General Meeting 10 Nov 2021: AGM Presentations
28 Oct 2021 Ticker News Cognitive Impairment: A drug for the treatment of Alzheimer’s
09 Aug 2021 ShareCafe ShareCafe Small Cap “Hidden Gems” Webinar presentation
15 Jul 2021 Stockhead These two ASX brain health stocks, boosted by FDA’s approval of Adulhelm, are kicking off clinical trials
15 Jul 2021 Biotech Daily Actinogen Enrols 1st XanaMIA Trial Patient
15 Jul 2021 The Market Herald Actinogen Medical (ASX:ACW) enrols first patient in Alzheimer’s Disease trial
15 Jul 2021 Monex Trading the World Here’s why the Actinogen (ASX:ACW) share price is rocketing 13% today
09 Jul 2021 Fragile X News Today FDA OKs Phase 2 Trial Design for Xanamem
23 Jun 2021 Stockhead Actinogen Medical gets a further boost from supportive FDA advice, shares up 7-fold in 2021
22 Jun 2021 The Motley Fool Here’s why the Actinogen Medical (ASX:ACW) share price is up 20%
21 Jun 2021 Biotech Daily Actinogen Appoints 2 CROs, Cogstate For XanaMIA
21 Jun 2021 The Market Herald Actinogen Medical (ASX:ACW) takes next step towards cortisol study
21 Jun 2021 Stockhead Dr Boreham’s Crucible: Time to make a song and dance about Actinogen (ASX:ACW)?
18 Jun 2021 Biotech Daily Dr Boreham’s Crucible: Actinogen Medical
16 Jun 2021 The Motley Fool Why is the Actinogen (ASX:ACW) share price up 414% in 3 months?
15 Jun 2021 Switzer Financial Group Dr Steven Gourlay from Actinogen | The CEO Masterclass
10 Jun 2021 Actinogen BIO Digital 2021: Company presentation (10-11 & 14-18 June 2021)
10 Jun 2021 Stockhead Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed
10 Jun 2021 Share Cafe Alzheimer’s Decision Sends Positive Message to Aussie Biotechs
08 Jun 2021 Stockhead FDA’s landmark approval of Biogen’s Alzheimer’s drug sends Cogstate up 60 per cent

Back
to top